Groundbreaking blood test rapidly diagnoses rare genetic diseases in babies

Two-year-old Kye Gray is nan only Australian pinch an ultra-rare familial information called Leigh's Disease.

The neurological information robs nan assemblage of power and causes progressive cognitive and beingness decline.

Like galore parents of children pinch uncommon illnesses, mum Louise Gray was anxious to find nan root of her baby's symptoms.

But she said nan family ran nan gauntlet of aesculapian mobility marks earlier nan Brisbane toddler's diagnosis.

That was until a revolutionary humor trial which promises to quickly diagnose thousands of uncommon diseases came to nan family's aid.

"There's been 15 reported cases that we're alert of astir nan world, and six of those cases are presently alive," Mrs Gray said.

"It's fixed america answers, which is what we didn't person for truthful long."

Ten years successful nan making, Melbourne researchers declare nan improvement offers "one trial to norm them all".

"Instead of doing a gene-specific test, we tin do 1 trial for astir half of nan 7000 uncommon diseases," Murdoch Children's Research Institute professor David Thorburn said.

"We deliberation it will summation nan number of diagnoses from nan genomic testing from possibly a 3rd to half of each patients, up to astir about 70, 75 per cent."

For families for illustration nan Grays, it tin besides let earlier entree to curen and eliminate nan request for costly and invasive procedures.

"It gives them closure and an extremity to this mobility of why, what happened, was it thing I did?" University of Melbourne subordinate professor Dr David Stroud said.

"It tin besides springiness nan patients entree to due treatments and for galore families tin reconstruct reproductive confidence, allowing them to person a patient child."

DOWNLOAD THE 9NEWS APP: Stay crossed each nan latest successful breaking news, sport, authorities and nan upwind via our news app and get notifications sent consecutive to your smartphone. Available connected the Apple App Store and Google Play.